|Day Low/High||0.58 / 0.61|
|52 Wk Low/High||0.09 / 0.75|
Publicly traded cannabis companies are expected to take big write downs on assets, and here's why it matters.
Following widely reported lung injuries and bans, the products struggle to come back as concerns over Covid-19 burn on.
Cannabis companies are finally feeling like this is their moment to shine.
Can the industry afford to lose 80% of its market and still make a profit?
As many in industry struggle, we preview reports to come.
Cannabis player came under scrutiny for number of store licenses in state.
These companies didn't make it any easier on themselves this year.
Canaccord cuts price target for the firm that's set to release earnings Nov. 20.